StockData
Elite Pharmaceuticals Inc logo

Elite Pharmaceuticals Inc (ELTP) stock

ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)

Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –

Earnings

Elite Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 16, 2027
Q3 FY2027 · estimated, during market hours
Revenue, Q2 FY2027
$40.10M
+10.5% on a year earlier
EPS, Q2 FY2027
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Elite Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2027ended Dec 31, 2026Feb 16, 2027Expected––––
Q2 FY2027ended Sep 30, 2026Nov 12, 2026after the close$40.10M+10.5%–Release
Q1 FY2027ended Jun 30, 2026Aug 13, 2026during market hours$32.40M-19.4%–Release
Q4 FY2026ended Mar 31, 2026Jun 29, 2026during market hours$148.90M––Release
Q3 FY2026ended Dec 31, 2025Feb 17, 2026during market hours$31.60M+119.4%–Release
Q2 FY2026ended Sep 30, 2025Nov 14, 2025during market hours$36.30M+92.1%–Release
Q1 FY2026ended Jun 30, 2025Aug 14, 2025during market hours$40.20M––Release
Q4 FY2025ended Mar 31, 2025Jun 30, 2025during market hours–––Release
Q3 FY2025ended Dec 31, 2024Feb 13, 2025during market hours$14.40M––Release
Q2 FY2025ended Sep 30, 2024Nov 14, 2024during market hours$18.90M––Release
Q1 FY2025ended Jun 30, 2024Aug 14, 2024during market hours–––Release
Q3 FY2024ended Dec 31, 2023Feb 14, 2024during market hours–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Elite Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Elite Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Elite Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Update
  4. Results
  5. Update
  6. Update
  7. Update
  8. Results
  9. Update
  10. Update
  11. Update
  12. Update
  13. Results
  14. Update
  15. Results

See a number that looks wrong?